Nervous Times for NDA Sponsors: The New Reality of FDA Drug Reviews

FDA is adopting a broad range of procedural changes in response to suggestions from outside critics to address drug safety issues. The most significant change, however, may be just a new state of mind.

Cole Werble

It’s not a written, formal policy, but there is a new rule for sponsors preparing new drug applications for review...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet